Phase II study of IRInotecan treatment after COmbined chemo‐immunotherapy for extensive‐stage small cell lung cancer: Protocol of IRICO study.

Autor: Tomono, Hiromi^1,2 (AUTHOR), Taniguchi, Hirokazu^1,3 (AUTHOR) hirokazu_pc@nagasaki-u.ac.jp, Fukuda, Minoru^3,4 (AUTHOR), Ikeda, Takaya² (AUTHOR), Nagashima, Seiji² (AUTHOR), Akagi, Kazumasa¹ (AUTHOR), Ono, Sawana¹ (AUTHOR), Umeyama, Yasuhiro¹ (AUTHOR), Shimada, Midori^1,5 (AUTHOR), Gyotoku, Hiroshi¹ (AUTHOR), Takemoto, Shinnosuke¹ (AUTHOR), Hisamatsu, Yasushi⁶ (AUTHOR), Morinaga, Ryotaro⁶ (AUTHOR), Tagawa, Ryuta⁷ (AUTHOR), Ogata, Ryosuke^1,7 (AUTHOR), Dotsu, Yosuke⁷ (AUTHOR), Senju, Hiroaki^7,8 (AUTHOR), Soda, Hiroshi⁷ (AUTHOR), Nakatomi, Katsumi⁹ (AUTHOR), Hayashi, Fumiko⁴ (AUTHOR)

Publikováno v: Thoracic Cancer. Oct2023, Vol. 14 Issue 28, p2890-2894. 5p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Dynamics of blood neutrophil‐related indices during nivolumab treatment may be associated with response to salvage chemotherapy for non‐small cell lung cancer: A hypothesis‐generating study

Autor: Soda, Hiroshi, Ogawara, Daiki, Fukuda, Yuichi, Tomono, Hiromi, Okuno, Daisuke, Koga, Seiko, Taniguchi, Hirokazu, Yoshida, Masataka, Harada, Tatsuhiko, Umemura, Asuka, Yamaguchi, Hiroyuki, Mukae, Hiroshi

Publikováno v: Thoracic Cancer, Vol 10, Iss 2, Pp 341-346 (2019)
Thoracic Cancer

Several recent studies have shown that salvage chemotherapy following PD-1 blockade produces high antitumor activity in some patients with non-small lung cancer (NSCLC). However, the underlying synergistic mechanisms remain uncertain. The blood neutr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d50274a91450eeb2505f90f3b8823500
https://doaj.org/article/dc34167674d345cd866b2e3e56886d39